Exhibit 10.21
AMENDMENT NO. 2
TO THE MATERIAL TRANSFER AGREEMENT
This Amendment No. 2 to the material transfer agreement (this “Amendment No. 2”) is retroactively effective as of January 22, 2023 (the “Amendment No. 2 Effective Date”) and executed as of March 6, 2024, by and between Avalyn Pharma Inc., having its registered office at 701 Pike Street, Suite 1500, Seattle, Washington 98101, USA (“Avalyn”), and PARI Pharma GmbH, having its principal place of business at Moosstrasse 3, 82319 Starnberg, Germany (“PARI”) (each of Avalyn and PARI being individually a “Party” and together the “Parties”).
NOW, THEREFORE, in consideration of the mutual covenants and agreements set forth herein and for good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Parties hereby agree as follows:
“WHEREAS, in addition to the transfer of Material, Avalyn may, from time to time, request that PARI perform certain services pursuant to Work Orders (as hereinafter defined) agreed in writing by the Parties.”
“1 PROVISION OF MATERIAL AND SERVICES”
“Applicable Laws and Standards” means (a) all laws, ordinances, rules, directives and regulations applicable to the Materials, the Evaluation Purpose, the Evaluation Studies, the Services or this Agreement, including without limitation applicable local laws and regulations in each relevant country, (b) applicable regulations and guidelines of the U.S. Food and Drug